EMBC Stock Overview
Embecta Corp., empresa de dispositivos médicos, se centra en el suministro de diversas soluciones para mejorar la salud y el bienestar de las personas diabéticas.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
+ 1 more risk
Embecta Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$12.76 |
| 52 Week High | US$32.00 |
| 52 Week Low | US$12.32 |
| Beta | 0.71 |
| 1 Month Change | -5.27% |
| 3 Month Change | -30.04% |
| 1 Year Change | -55.01% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | n/a |
Recent News & Updates
Recent updates
Embecta's (NASDAQ:EMBC) Dividend Will Be $0.15
Feb 21
Embecta Corp.'s (NASDAQ:EMBC) Prospects Need A Boost To Lift Shares
Jul 16Embecta Corp. (NASDAQ:EMBC) Shares Could Be 37% Below Their Intrinsic Value Estimate
Mar 30Embecta Corp. Just Recorded A 22% EPS Beat: Here's What Analysts Are Forecasting Next
Feb 17Embecta: Comments On 2nd Earnings Since Spin Off
Sep 04Some Investors May Be Willing To Look Past Embecta's (NASDAQ:EMBC) Soft Earnings
Aug 23Embecta GAAP EPS of $1.07 beats by $0.20, revenue of $291.1M beats by $14.24M
Aug 15Embecta Is A Winner In A Growing Market
Jun 07Embecta: Not Love At First Sight
Apr 04Shareholder Returns
| EMBC | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -3.8% | -2.1% | -1.1% |
| 1Y | -55.0% | 7.7% | 25.8% |
Rentabilidad frente al sector: EMBC obtuvo unos resultados inferiores a los del sector US Medical Equipment , que el año pasado arrojó un rendimiento del 8.3%.
Rentabilidad vs. Mercado: EMBC obtuvo unos resultados inferiores a los del mercado US, que fue del 20.5% el año pasado.
Price Volatility
| EMBC volatility | |
|---|---|
| EMBC Average Weekly Movement | 6.2% |
| Medical Equipment Industry Average Movement | 7.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: EMBCha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de EMBC (7%) se ha mantenido estable durante el año pasado.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1924 | 2,200 | Dev Kurdikar | https://www.embecta.com |
Embecta Corp., empresa de dispositivos médicos, se centra en el suministro de diversas soluciones para mejorar la salud y el bienestar de las personas que viven con diabetes. Sus productos incluyen agujas para pluma, jeringuillas y dispositivos de inyección de seguridad, así como aplicaciones digitales para ayudar a las personas a controlar la diabetes de sus pacientes. La empresa vende sus productos principalmente a mayoristas y distribuidores de Estados Unidos e internacionales.
Embecta Corp. Fundamentals Summary
| EMBC fundamental statistics | |
|---|---|
| Market cap | US$735.86m |
| Earnings (TTM) | US$55.30m |
| Revenue (TTM) | US$1.12b |
13.3x
P/E Ratio0.7x
P/S RatioIs EMBC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EMBC income statement (TTM) | |
|---|---|
| Revenue | US$1.12b |
| Cost of Revenue | US$375.40m |
| Gross Profit | US$747.00m |
| Other Expenses | US$691.70m |
| Earnings | US$55.30m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.96 |
| Gross Margin | 66.55% |
| Net Profit Margin | 4.93% |
| Debt/Equity Ratio | -201.9% |
How did EMBC perform over the long term?
See historical performance and comparison